Satoshi Ichikawa

4.2k total citations
155 papers, 3.3k citations indexed

About

Satoshi Ichikawa is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Satoshi Ichikawa has authored 155 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 100 papers in Molecular Biology, 85 papers in Organic Chemistry and 50 papers in Pharmacology. Recurrent topics in Satoshi Ichikawa's work include Microbial Natural Products and Biosynthesis (45 papers), Carbohydrate Chemistry and Synthesis (42 papers) and Chemical Synthesis and Analysis (31 papers). Satoshi Ichikawa is often cited by papers focused on Microbial Natural Products and Biosynthesis (45 papers), Carbohydrate Chemistry and Synthesis (42 papers) and Chemical Synthesis and Analysis (31 papers). Satoshi Ichikawa collaborates with scholars based in Japan, United States and Czechia. Satoshi Ichikawa's co-authors include Akira Matsuda, Shinpei Hirano, Dale L. Boger, Satoshi Shuto, Tetsuya Tanino, Akira Katsuyama, Kazuki Yamamoto, Seok‐Yong Lee, Bayan Al-Dabbagh and Ahmed Bouhss and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of the American Chemical Society.

In The Last Decade

Satoshi Ichikawa

146 papers receiving 3.2k citations

Peers

Satoshi Ichikawa
Cheng‐Wei Tom Chang United States
Rebecca J. M. Goss United Kingdom
Kithsiri Herath United States
Jiyong Hong United States
Steven G. Van Lanen United States
Cheng‐Wei Tom Chang United States
Satoshi Ichikawa
Citations per year, relative to Satoshi Ichikawa Satoshi Ichikawa (= 1×) peers Cheng‐Wei Tom Chang

Countries citing papers authored by Satoshi Ichikawa

Since Specialization
Citations

This map shows the geographic impact of Satoshi Ichikawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Satoshi Ichikawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Satoshi Ichikawa more than expected).

Fields of papers citing papers by Satoshi Ichikawa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Satoshi Ichikawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Satoshi Ichikawa. The network helps show where Satoshi Ichikawa may publish in the future.

Co-authorship network of co-authors of Satoshi Ichikawa

This figure shows the co-authorship network connecting the top 25 collaborators of Satoshi Ichikawa. A scholar is included among the top collaborators of Satoshi Ichikawa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Satoshi Ichikawa. Satoshi Ichikawa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kobayashi, Masakazu, Kenichi Matsuda, Hanako Fukano, et al.. (2025). Non-ribosomal peptide cyclase-directed chemoenzymatic synthesis of lariat lipopeptides. Nature Chemistry. 18(1). 180–188.
2.
Artsimovitch, Irina, et al.. (2025). Structure–Activity Relationship of Pseudouridimycin Focusing on the Improvement of Chemical Stability. Journal of Medicinal Chemistry. 68(15). 15461–15482.
3.
Yamamoto, Kazuki, Ken Takashima, Ryuta Muromoto, et al.. (2025). A selective RPL15 PROTAC degrader enhances anti-PD-1 immunotherapy in a murine melanoma tumor model. Oncogene. 44(50). 4846–4854.
4.
Katsuyama, Akira, et al.. (2024). Modulation of proteasome subunit selectivity of syringolins. Bioorganic & Medicinal Chemistry. 106. 117733–117733. 1 indexed citations
5.
Konishi, Hiroaki, Akira Katsuyama, Koji Nakagawa, et al.. (2024). Synthesis and biological evaluation of echinomycin analogues as potential colon cancer agent. Scientific Reports. 14(1). 7628–7628. 1 indexed citations
6.
Katsuyama, Akira, Toyotaka Sato, Satoshi Takahashi, et al.. (2023). Discovery of Biologically Optimized Polymyxin Derivatives Facilitated by Peptide Scanning and In Situ Screening Chemistry. Journal of the American Chemical Society. 145(6). 3665–3681. 11 indexed citations
7.
Yamamoto, Kazuki, et al.. (2022). Design, synthesis and conformation-activity relationship analysis of LNA/BNA-type 5′-O-aminoribosyluridine as MraY inhibitors. Bioorganic & Medicinal Chemistry. 65. 116744–116744. 6 indexed citations
8.
Mashalidis, Ellene H., Toyotaka Sato, Kazuki Yamamoto, et al.. (2022). Synthesis of macrocyclic nucleoside antibacterials and their interactions with MraY. Nature Communications. 13(1). 7575–7575. 18 indexed citations
9.
Sekine, Daisuke, Akihiro Ito, Satoko Maeda, et al.. (2019). Synthesis of All Stereoisomers of Monomeric Spectomycin A1/A2 and Evaluation of Their Protein SUMOylation‐Inhibitory Activity. Chemistry - A European Journal. 25(35). 8387–8392. 6 indexed citations
10.
Ichikawa, Satoshi, et al.. (2019). Novel adenosine-derived inhibitors of Cryptosporidium parvum inosine 5′-monophosphate dehydrogenase. The Journal of Antibiotics. 72(12). 934–942. 3 indexed citations
11.
Yamamoto, Kazuki & Satoshi Ichikawa. (2019). Tunicamycin: chemical synthesis and biosynthesis. The Journal of Antibiotics. 72(12). 924–933. 24 indexed citations
12.
Sasaki, Michihito, Naoto Ito, Makoto Sugiyama, et al.. (2018). Ribavirin-related compounds exert in vitro inhibitory effects toward rabies virus. Antiviral Research. 154. 1–9. 25 indexed citations
13.
Yoo, Jiho, Ellene H. Mashalidis, Alvin C. Y. Kuk, et al.. (2018). GlcNAc-1-P-transferase–tunicamycin complex structure reveals basis for inhibition of N-glycosylation. Nature Structural & Molecular Biology. 25(3). 217–224. 108 indexed citations
14.
Inai, Makoto, Hiroshi Maita, Takao Nomura, et al.. (2017). Divergent synthesis of kinase inhibitor derivatives, leading to discovery of selective Gck inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(10). 2144–2147.
15.
Matsuda, Akira, et al.. (2015). Structure–activity relationship study of syringolin A as a potential anticancer agent. Bioorganic & Medicinal Chemistry Letters. 25(21). 4872–4877. 9 indexed citations
16.
Ichikawa, Satoshi, et al.. (2011). Development of Antibacterial Agents Active against Drug-resistant Bacterial Pathogens Based on Total Synthesis of Nucleoside Natural Products. Journal of Synthetic Organic Chemistry Japan. 69(9). 1020–1033. 1 indexed citations
17.
Ichikawa, Satoshi, Noboru Yamada, Noriyuki Suetsugu, Masamitsu Wada, & Akeo Kadota. (2011). Red Light, Phot1 and JAC1 Modulate Phot2-Dependent Reorganization of Chloroplast Actin Filaments and Chloroplast Avoidance Movement. Plant and Cell Physiology. 52(8). 1422–1432. 29 indexed citations
18.
Kaysser, Leonard, et al.. (2010). A New Arylsulfate Sulfotransferase Involved in Liponucleoside Antibiotic Biosynthesis in Streptomycetes. Journal of Biological Chemistry. 285(17). 12684–12694. 31 indexed citations
19.
Hirano, Shinpei, Satoshi Ichikawa, & Akira Matsuda. (2007). Design and synthesis of diketopiperazine and acyclic analogs related to the caprazamycins and liposidomycins as potential antibacterial agents. Bioorganic & Medicinal Chemistry. 16(1). 428–436. 43 indexed citations
20.
Kurihara, Hideyuki, Jun Kawabata, Satoshi Ichikawa, & Junya Mizutani. (1990). (-)-ε-Viniferin and Related Oligostilbenes from Carex pumila Thunb. (Cyperaceae)(Organic Chemistry). Agricultural and Biological Chemistry. 54(4). 1097–1099. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026